|
1
|
The human apolipoprotein C-II gene sequence contains a novel chromosome 19-specific minisatellite in its third intron.
|
J Biol Chem
|
1987
|
2.85
|
|
2
|
Individual products of the adenovirus 12S and 13S EIa mRNAs stimulate viral EIIa and EIII expression at the transcriptional level.
|
Proc Natl Acad Sci U S A
|
1984
|
2.64
|
|
3
|
Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.
|
J Clin Invest
|
1995
|
2.05
|
|
4
|
Transcriptional analysis of the adenovirus-5 EIII promoter: absence of sequence specificity for stimulation by EIa gene products.
|
Nucleic Acids Res
|
1985
|
2.04
|
|
5
|
Human apolipoprotein CIII gene expression is regulated by positive and negative cis-acting elements and tissue-specific protein factors.
|
J Biol Chem
|
1988
|
1.64
|
|
6
|
Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors.
|
J Biol Chem
|
2001
|
1.61
|
|
7
|
c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity.
|
Endocrinology
|
1999
|
1.60
|
|
8
|
Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels.
|
J Lipid Res
|
1994
|
1.40
|
|
9
|
Far upstream sequences are required for efficient transcription from the adenovirus-2 E1A transcription unit.
|
Nucleic Acids Res
|
1983
|
1.40
|
|
10
|
Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
|
Diabetes
|
2000
|
1.34
|
|
11
|
A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes.
|
Endocrinology
|
2001
|
1.19
|
|
12
|
Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements.
|
J Biol Chem
|
1988
|
1.18
|
|
13
|
Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.
|
J Clin Invest
|
1994
|
1.08
|
|
14
|
Sequence-specific activation of transcription by adenovirus EIa products is observed in HeLa cells but not in 293 cells.
|
Mol Cell Biol
|
1986
|
1.05
|
|
15
|
Cell type-specific expression of the human apoB gene is controlled by two cis-acting regulatory regions.
|
J Biol Chem
|
1988
|
1.04
|
|
16
|
A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E.
|
J Lipid Res
|
1999
|
0.96
|
|
17
|
Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.
|
J Lipid Res
|
1995
|
0.92
|
|
18
|
Mitogen-activated protein kinase regulates transcription of the ApoCIII gene. Involvement of the orphan nuclear receptor HNF4.
|
J Biol Chem
|
1999
|
0.92
|
|
19
|
Characterization of a dominant negative mutant form of the HNF-4 orphan receptor.
|
Nucleic Acids Res
|
1996
|
0.92
|
|
20
|
Apo CIII gene transcription is regulated by a cytokine inducible NF-kappa B element.
|
Nucleic Acids Res
|
1994
|
0.90
|
|
21
|
Nuclear factors AF-1 and C/EBP bind to the human ApoB gene promoter and modulate its transcriptional activity in hepatic cells.
|
J Biol Chem
|
1990
|
0.87
|
|
22
|
Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
|
Diabetes
|
1999
|
0.86
|
|
23
|
Three isoforms of a hepatocyte nuclear factor-4 transcription factor with tissue- and stage-specific expression in the adult mosquito.
|
J Biol Chem
|
1998
|
0.79
|
|
24
|
Regulation of cytochrome P450 in cultured human colonic cells.
|
Arch Biochem Biophys
|
1993
|
0.79
|
|
25
|
c-Myc does not require max for transcriptional activity in PC-12 cells.
|
Mol Cell Neurosci
|
1994
|
0.79
|
|
26
|
A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor.
|
J Lipid Res
|
1998
|
0.76
|
|
27
|
Studies of heterologous promoter trans-activation by the HTLV-II tax protein.
|
Nucleic Acids Res
|
1989
|
0.75
|